Clinical Trial Update: Dapagliflozin in Allo-HCT for aGVHD [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating dapagliflozin for acute graft-versus-host disease after allogeneic stem cell transplantation, and the study is currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• Dapagliflozin (dapagliflozin)

Snippet

Sponsor: The First Affiliated Hospital of Soochow University | Conditions: Graft-versus-host Disease (GVHD) | Phase 2 | Status: RECRUITING